重组人血清白蛋白（rHSA）
Recombinant Human Serum Albumin (rHSA) 是一种非糖基化的单体血浆蛋白，作为维持血浆胶体渗透压的核心因子。Recombinant Human Serum Albumin (rHSA) 具有载体、代谢调节、解毒、抗氧化及拟酶等多种生理功能。Recombinant Human Serum Albumin (rHSA) 不仅能通过特定残基清除活性氧氮物种并结合多种内外源性化合物以维持氧化还原稳态，还可作为癌症及炎症等多种疾病的生物标志物。Recombinant Human Serum Albumin (rHSA) 广泛支持可植入材料、手术粘合剂及配体捕获等开发，可用于低血容量症、肝衰竭、严重脓毒症及各类创伤复苏等危急重症的研究。
苏丹IV
Sudan IV 是一种芳香烃受体 (AhR) 的激动剂，可激活下游信号通路，诱导 CYP1A1 表达。Sudan IV 通过激活 AhR-ARNT 异二聚体，结合 DNA 上的外源性反应元件 (XRE)，促进 CYP1A1 基因转录，从而增强药物代谢酶活性。Sudan IV 可用于研究工业染料的毒性机制、与血清蛋白 (如牛血清白蛋白 BSA) 的相互作用对体内分布的影响。Sudan IV 是一种脂溶性重氮染料、可用于冰冻切片上对脂类、甘油三酯和脂蛋白进行染色。
罗汉果苷 III
Mogroside III 是一种葫芦烷型三萜糖苷。Mogroside III 对麦芽糖酶 (maltase) 有抑制作用，IC50 值为 1.6 mM。Mogroside III 通过促进卵丘细胞自噬 (autophagy) 来增强卵母细胞的发育潜力。Mogroside III 作为低极性苷类组分 (L-SGgly) 的活性成分，L-SGgly 可通过提高血清 GLP-1 水平改善胰岛素抵抗、降低 IL-6 水平，兼具降糖、调脂和抗炎作用。Mogroside III 可被用于研究 2 型糖尿病和辅助生殖技术。
苏丹IV (标准品)
Sudan IV (Standard) (Solvent Red 24 (Standard)) 是 Sudan IV (HY-D0932) 的分析标准品。本产品用于研究及分析应用。Sudan IV 是一种芳香烃受体 (AhR) 的激动剂，可激活下游信号通路，诱导 CYP1A1 表达。Sudan IV 通过激活 AhR-ARNT 异二聚体，结合 DNA 上的外源性反应元件 (XRE)，促进 CYP1A1 基因转录，从而增强药物代谢酶活性。Sudan IV 可用于研究工业染料的毒性机制、与血清蛋白 (如牛血清白蛋白 BSA) 的相互作用对体内分布的影响。Sudan IV 是一种脂溶性重氮染料、可用于冰冻切片上对脂类、甘油三酯和脂蛋白进行染色。
苏丹IV-d6
Sudan IV-d6 (Solvent Red 24-d6) 是氘代标记的 Sudan IV (HY-D0932)。Sudan IV 是一种芳香烃受体 (AhR) 的激动剂，可激活下游信号通路，诱导 CYP1A1 表达。Sudan IV 通过激活 AhR-ARNT 异二聚体，结合 DNA 上的外源性反应元件 (XRE)，促进 CYP1A1 基因转录，从而增强药物代谢酶活性。Sudan IV 可用于研究工业染料的毒性机制、与血清蛋白 (如牛血清白蛋白 BSA) 的相互作用对体内分布的影响。Sudan IV 是一种脂溶性重氮染料、可用于冰冻切片上对脂类、甘油三酯和脂蛋白进行染色。
番茄皂苷A
Esculeoside A 是一种具有口服活性的螺甾烷型甾体生物碱糖苷，存在于 Lycopersicon esculentum var. cerasiforme 和 Lycopersicon esculentum 的成熟果实中。Esculeoside A 是一种心脏保护剂和降糖剂。Esculeoside A 可调控心脏组织中的 NF-κB、Nrf2/Keap1 信号通路，减轻炎症反应与凋亡 (apoptosis)，阻止心肌细胞肥大，并降低血清脂质水平。Esculeoside A 可通过调控 IRS-1、GCK、AMPK 和 PEPCK 的表达来调节糖代谢，降低空腹血糖，改善葡萄糖耐量。Esculeoside A 可抑制 TLR4/p-NFκB 信号通路，从而阻碍树突状细胞成熟及异体 T 细胞增殖，并抑制乳腺癌与黑色素瘤细胞的生长。Esculeoside A 可抑制 ACAT 活性，减少巨噬细胞中胆固醇酯的积累。Esculeoside A 可用于糖尿病心肌病、2 型糖尿病、特应性皮炎、肿瘤及动脉粥样硬化性疾病的研究。
苏丹IV
Sudan IV 是一种芳香烃受体 (AhR) 的激动剂，可激活下游信号通路，诱导 CYP1A1 表达。Sudan IV 通过激活 AhR-ARNT 异二聚体，结合 DNA 上的外源性反应元件 (XRE)，促进 CYP1A1 基因转录，从而增强药物代谢酶活性。Sudan IV 可用于研究工业染料的毒性机制、与血清蛋白 (如牛血清白蛋白 BSA) 的相互作用对体内分布的影响。Sudan IV 是一种脂溶性重氮染料、可用于冰冻切片上对脂类、甘油三酯和脂蛋白进行染色。
苏丹IV (标准品)
Sudan IV (Standard) (Solvent Red 24 (Standard)) 是 Sudan IV (HY-D0932) 的分析标准品。本产品用于研究及分析应用。Sudan IV 是一种芳香烃受体 (AhR) 的激动剂，可激活下游信号通路，诱导 CYP1A1 表达。Sudan IV 通过激活 AhR-ARNT 异二聚体，结合 DNA 上的外源性反应元件 (XRE)，促进 CYP1A1 基因转录，从而增强药物代谢酶活性。Sudan IV 可用于研究工业染料的毒性机制、与血清蛋白 (如牛血清白蛋白 BSA) 的相互作用对体内分布的影响。Sudan IV 是一种脂溶性重氮染料、可用于冰冻切片上对脂类、甘油三酯和脂蛋白进行染色。
重组人血清白蛋白（rHSA）
Recombinant Human Serum Albumin (rHSA) 是一种非糖基化的单体血浆蛋白，作为维持血浆胶体渗透压的核心因子。Recombinant Human Serum Albumin (rHSA) 具有载体、代谢调节、解毒、抗氧化及拟酶等多种生理功能。Recombinant Human Serum Albumin (rHSA) 不仅能通过特定残基清除活性氧氮物种并结合多种内外源性化合物以维持氧化还原稳态，还可作为癌症及炎症等多种疾病的生物标志物。Recombinant Human Serum Albumin (rHSA) 广泛支持可植入材料、手术粘合剂及配体捕获等开发，可用于低血容量症、肝衰竭、严重脓毒症及各类创伤复苏等危急重症的研究。
罗汉果苷 III
Mogroside III 是一种葫芦烷型三萜糖苷。Mogroside III 对麦芽糖酶 (maltase) 有抑制作用，IC50 值为 1.6 mM。Mogroside III 通过促进卵丘细胞自噬 (autophagy) 来增强卵母细胞的发育潜力。Mogroside III 作为低极性苷类组分 (L-SGgly) 的活性成分，L-SGgly 可通过提高血清 GLP-1 水平改善胰岛素抵抗、降低 IL-6 水平，兼具降糖、调脂和抗炎作用。Mogroside III 可被用于研究 2 型糖尿病和辅助生殖技术。
番茄皂苷A
Esculeoside A 是一种具有口服活性的螺甾烷型甾体生物碱糖苷，存在于 Lycopersicon esculentum var. cerasiforme 和 Lycopersicon esculentum 的成熟果实中。Esculeoside A 是一种心脏保护剂和降糖剂。Esculeoside A 可调控心脏组织中的 NF-κB、Nrf2/Keap1 信号通路，减轻炎症反应与凋亡 (apoptosis)，阻止心肌细胞肥大，并降低血清脂质水平。Esculeoside A 可通过调控 IRS-1、GCK、AMPK 和 PEPCK 的表达来调节糖代谢，降低空腹血糖，改善葡萄糖耐量。Esculeoside A 可抑制 TLR4/p-NFκB 信号通路，从而阻碍树突状细胞成熟及异体 T 细胞增殖，并抑制乳腺癌与黑色素瘤细胞的生长。Esculeoside A 可抑制 ACAT 活性，减少巨噬细胞中胆固醇酯的积累。Esculeoside A 可用于糖尿病心肌病、2 型糖尿病、特应性皮炎、肿瘤及动脉粥样硬化性疾病的研究。
Sudan IV-d6 (Solvent Red 24-d6) 是氘代标记的 Sudan IV (HY-D0932)。Sudan IV 是一种芳香烃受体 (AhR) 的激动剂，可激活下游信号通路，诱导 CYP1A1 表达。Sudan IV 通过激活 AhR-ARNT 异二聚体，结合 DNA 上的外源性反应元件 (XRE)，促进 CYP1A1 基因转录，从而增强药物代谢酶活性。Sudan IV 可用于研究工业染料的毒性机制、与血清蛋白 (如牛血清白蛋白 BSA) 的相互作用对体内分布的影响。Sudan IV 是一种脂溶性重氮染料、可用于冰冻切片上对脂类、甘油三酯和脂蛋白进行染色。
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
MedchemExpress Validation 03
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
MedchemExpress Validation 04
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
